A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease
Authors:
- Ciro ImbimboCICiro Imbimbo
- Nicola LongoNLNicola Longo
- Ferdinando FuscoFFFerdinando Fusco
- Paolo VerzePVPaolo Verze
- Francesco MangiapiaFMFrancesco Mangiapia
- Massimiliano CretaMCMassimiliano Creta
- Vincenzo MironeVMVincenzo Mirone
- 1 August 2009
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 56 (2) , 363-370
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Impact of Peyronie's Disease on Sexual and Psychosocial Functioning: Qualitative Findings in Patients and ControlsThe Journal of Sexual Medicine, 2008
- A new mouse model of Peyronie's disease: An increased expression of hypoxia-inducible factor-1 target genes during the development of penile changesThe International Journal of Biochemistry & Cell Biology, 2008
- A Critical Analysis of Nonsurgical Treatment of Peyronie’s DiseaseEuropean Urology, 2006
- Prevalence of Peyronie’s Disease Among Patients With Erectile DysfunctionEuropean Urology, 2006
- An alternative non-invasive treatment for Peyronie's diseaseInternational braz j urol, 2004
- Questionable Efficacy of Extracorporeal Shock Wave Therapy for Peyronie’s Disease:: Results of a Prospective ApproachJournal of Urology, 2004
- Clinical presentations of Peyronie's diseaseInternational Journal Of Impotence Research, 2002
- A New Biopsy Technique to Investigate Peyronie's Disease Associated Histologic Alterations: Results with Two Different Forms of TherapyEuropean Urology, 2002
- Extracorporal Shock Wave Therapy in the Treatment of Peyronie’s DiseaseEuropean Urology, 2000
- EXTRACORPOREAL SHOCK WAVE THERAPY IN ORTHOPEDICSInternational Journal of Technology Assessment in Health Care, 2000